| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2017 ( Subtotal = -$671,618 ) |
| | 2017 | 2014 | ZYNERBA PHARMACEUTICALS, INC. | 80 W LANCASTER AVE SUITE 300 | DEVON | PA | 19333-1331 | CHESTER | USA | R42DA032191 | Transdermal Naltrexone for Opiate Addiction and Alcoholism | 000 | 2 | NIH | 4/7/2017 | -$653,909 |
| | 2017 | 2013 | ZYNERBA PHARMACEUTICALS, INC. | 80 W LANCASTER AVE SUITE 300 | DEVON | PA | 19333-1331 | CHESTER | USA | R21DA031439 | Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi | 000 | 2 | NIH | 1/9/2017 | -$17,709 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2014 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R42DA032191 | Transdermal Naltrexone for Opiate Addiction and Alcoholism | 000 | 2 | NIH | 3/19/2015 | $0 |
| | 2015 | 2013 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R21DA031439 | Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi | 000 | 2 | NIH | 10/31/2014 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $695,993 ) |
| | 2014 | 2014 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R42DA032191 | Transdermal Naltrexone for Opiate Addiction and Alcoholism | 000 | 2 | NIH | 11/29/2013 | $695,993 |
|
| Issue Date FY: 2013 ( Subtotal = $230,144 ) |
| | 2013 | 2013 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R21DA031439 | Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi | 001 | 2 | NIH | 5/16/2013 | $14,384 |
| | 2013 | 2013 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R21DA031439 | Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi | 000 | 2 | NIH | 4/16/2013 | $215,760 |
| | 2013 | 2012 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R42DA032191 | Transdermal Naltrexone for Opiate Addiction and Alcoholism | 000 | 1 | NIH | 6/13/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $741,404 ) |
| | 2012 | 2012 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R42DA032191 | Transdermal Naltrexone for Opiate Addiction and Alcoholism | 000 | 1 | NIH | 7/26/2012 | $537,779 |
| | 2012 | 2012 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R21DA031439 | Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi | 000 | 1 | NIH | 7/11/2012 | $203,625 |
| | 2012 | 2010 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | RC2DA028984 | TRANSDERMAL CANNABINOID PRODRUG TREATMENT FOR CANNABIS WITHDRAWAL AND DEPENDENCE | 000 | 2 | NIH | 5/9/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $160,500 ) |
| | 2011 | 2011 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R43DA032161 | TRANSDERMAL CANNABIDIOL PRODRUG DELIVERY | 000 | 1 | NIH | 7/14/2011 | $160,500 |
|
| Issue Date FY: 2010 ( Subtotal = $1,932,519 ) |
| | 2010 | 2010 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | RC2DA028984 | TRANSDERMAL CANNABINOID PRODRUG TREATMENT FOR CANNABIS WITHDRAWAL AND DEPENDENCE | 000 | 2 | NIH | 9/17/2010 | $1,932,519 |
| | 2010 | 2009 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R43DA026266 | TRANSDERMAL DELIVERY OF BUPRENORPHINE PRODRUGS | 000 | 1 | NIH | 12/10/2009 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $2,195,771 ) |
| | 2009 | 2009 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | R43DA026266 | TRANSDERMAL DELIVERY OF BUPRENORPHINE PRODRUGS | 000 | 1 | NIH | 6/2/2009 | $115,025 |
| | 2009 | 2009 | ALLTRANZ INC | 4080 WEBER WAY | LEXINGTON | KY | 40514 | FAYETTE | USA | RC2DA028984 | TRANSDERMAL CANNABINOID PRODRUG TREATMENT FOR CANNABIS WITHDRAWAL AND DEPENDENCE | 000 | 1 | NIH | 9/30/2009 | $2,080,746 |
|
|
